Acucela, Otsuka Enter Deals For Eye Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Early stage and late stage pacts add proof of Japan’s growing interest in the U.S.
You may also be interested in...
Acucela Strikes Third Ophthalmology Deal With Otsuka For Glaucoma Drug
Building on deals in AMD and dry eye, the U.S. eye care startup will conduct trials on a novel glaucoma treatment, with an option to co-promote.
Acucela Strikes Third Ophthalmology Deal With Otsuka For Glaucoma Drug
Building on deals in AMD and dry eye, the U.S. eye care startup will conduct trials on a novel glaucoma treatment, with an option to co-promote.
Alcon To Try Glaxo’s Ariflo For Dry Eye
Swiss firm builds pipeline with help from GSK and Origenis in latest eye care in-licensing deals.